Current radiologic interventions in hepatocellular carcinoma

Journal of the College of Physicians and Surgeons Pakistan

Volumn 16, Issue 9, 2006, Pages 617-621

  Qasmi, Imran Masoud ^a   Naeem, Tahir ^b   Saeed, Farrukh ^a   Mirza, Shakeel Ahmed ^a   Khan, Muhammad Asad ^a   Bhatti, Muhammad Asghar ^a  

^a CMH   (Pakistan)

^b PAF Hospital   (Pakistan)

Author keywords

Hepatocellular carcinoma; Percutaneous ethanol injection; Radiofrequency ablation; Radiological interventions; Trans arterial embolization

Indexed keywords

ALCOHOL; ANTINEOPLASTIC AGENT; INTERFERON; YTTRIUM 90;

ANGIOGRAPHY; ARTICLE; BEAM THERAPY; BILE DUCT DISEASE; BILE DUCT INJURY; BLEEDING; BURN; CANCER MORTALITY; CANCER PALLIATIVE THERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CAUSE OF DEATH; CHEMOEMBOLIZATION; CHOLANGITIS; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONSERVATIVE TREATMENT; COST CONTROL; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DOSE RESPONSE; DRUG FEVER; ECHOGRAPHY; FLU LIKE SYNDROME; HAIR LOSS; HEMOPERITONEUM; HUMAN; INFECTION; INJECTION PAIN; INTERMETHOD COMPARISON; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FAILURE; LIVER HEMORRHAGE; LOW LEVEL LASER THERAPY; LUNG DISEASE; MAGNETOTHERAPY; MICROWAVE RADIATION; NAUSEA; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PORTAL VEIN THROMBOSIS; RADIOFREQUENCY ABLATION; RECURRENCE RISK; RISK ASSESSMENT; SURGICAL RISK; SURVIVAL RATE; SURVIVAL TIME; TREATMENT CONTRAINDICATION; TREATMENT FAILURE;

ANGIOGRAPHY; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; CHEMOEMBOLIZATION, THERAPEUTIC; DIAGNOSIS, DIFFERENTIAL; HUMANS; LIVER NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33749983421     PISSN: 1022386X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Fung J, Marsh W. The quandary over liver transplantation for hepatocellular carcinoma: the greater sin? Liver Transpl 2002; 8: 775-7.
2. El Sarag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Eng J Med 1999; 340:745-50.
3. Centre for Excellence in Molecular Biology. Diagnosis of infectious diseases. Lahore: Punjab University. The Centre.
4. Chiesa R, Donato F, Tagger A, Favret M, Ribero ML, Nardi G. et al. Etiology of hepatocellular carcinoma in Italian patients with and without cirrhosis. Cancer Epidemiol Biomarkers Prev 2000; 9: 213-6.
5. Solmi L, Primerano AMM, Gandolfi L. Ultrasound follow-up of patients at risk of hepatocellular carcinoma: results of a prospective study in 360 cases. Am J Gastroenterol 1996; 91: 1189-914.
6. Bartalozzi C, Lencioni R, Caramella D, Palla A, Bassi AM, Di candio G. Small hepatocellular carcinoma (HCC). Detection with US, CT, MR imaging, DSA, and lipoidal-CT. Acta Radiol 1996; 37: 69-74.
7. Khokhar N, Aijazi I, Gill ML. Spectrum of hepatocellular carcinoma at Shifa International Hospital, Islamabad. J Ayub Med Coll Abbottabad 2003; 15: 1-4.
8. Michael DR, Chapman WC, Brockenbrough AT. The practicality of chronic hepatic artery infusion therapy of primary and metastatic hepatic malignancies: ten-year results of 124 patients in a prospective protocol. Cancer 1981; 177: 405-10.
9. Lo CM, Ngan H, Tso WK, Liu CL, Lam CM, Poon RT, et al. Randomized controlled trial of transarterial lipoidol chemoembolization for unresectable hepatocellular carcinom. Hepatology 2002; 35:1164-71.
10. Llovet JM, Real MI, Montana X, Planas R, Coll S, Aponte J, et al. Arterial embolization or chemoembolization versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomized controlled trial. Lancet 2002: 359:1734-9.
11. A comparison of lipoidol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. Group d' Etude et de Traitement du carcinoma hepatocellular. N Engl J Med 1995; 332:1256-61.
12. Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology 2003; 37: 429-42.
13. Takayasu K, Shima Y, Muramatsu Y, Moriyama N, Yamada T, Makuuchi M, et al. Hepatocellular carcinoma: treatment with intra-arterial ionized oil with and without chemotherapeutic agents. Radiology 1987; 162: 345-51.
14. Georgiades CS, Hong K, D'Angelo M, Geschwind JF. Safety and efficacy of transarterial chemoembolization in patients with unresectable hepatocellular carcinoma and portal vein thrombosis. J Vasc Interv Radiol 2005; 16:1653-9.
15. Lencioni R, Cioni D, Crocetti L, Franchini C, Pina CD, Lera J, et al. Early stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. Radiology 2005; 234: 961-7.
16. Zerbini A, Pilli M, Penna A, Pelosi G, Schianchi C, Molinari A, et al. Radiofrequency thermal ablation of hepatocellular carcinoma liver nodules can activate and enhance tumor-specific T-cell responses. Cancer Res 2006; 66: 1139-46.
17. Livraghi T, Bolondi L, Lazzaroni S, Marin & Morabito A, Rapaccini GL, et al. Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis: a study on 207 patients. Cancer 1992; 69: 925-9.
18. Lin SM, Lin DY, Lin CJ. Percutaneous ethanol therapy in 47 cirrhotic patients with hepatocellular carcinoma 5 cm or less: a long-term result. Int J Clin Pract 1999; 53: 257-62.
19. Bastid C, Azar C, Sahel J. Ultrasound guided percutaneous ethanol treatment of hepatic neoplasms: a therapeutic alternative in the nineties. Ultrasound Med Biol 1995; 21:129-31.
20. Vilana R, Bruix J, Bru C, Ayuso C, Sole M, Rodes J. Tumour size determines the efficacy of percutaneous ethanol injection for the treatment of small hepatocellular carcinoma. Hepatology 1992;16:353-7.
21. Shibata T, Kojimi N, Tabuchi T, Itoh K, Ikai I, Yamaoka Y, et al. Transthoracic percutaneous ethanol injection therapy for hepatocellular carcinomas located beneath the diaphragm. J Vasc Inter Radiol 1998;9(IPt1):97-1 00.
22. Ishii H, Okada S, Okusaka T, Yoshimori M, Nakasuka H, Shimada K, et al. Needle tract implantation of hepatocellular carcinoma after percutaneous ethanol injection. Cancer 1698;82: 1638-42.
23. Di Stasi M, Buscarini L, Livraghi T, Giorgio A, Salmi A, De Sio I, et al. Percutaneous ethanol injection in the treatment of hepatocellular carcinoma. A multicenter Survey of evaluation practices and complication rates. Scrand J Gastroenterol 1997; 32:1168-73.
24. Ohnishi K, Yoshioka H, Ito S, Fujiwara K. Prospective randomized controlled trial comparing percutaneous acetic acid injection and percutaneous ethanol injection for small hepatocellur carcinoma (HCC). Hepatology 1998; 27: 67-72.
25. Ryder SD, Guidelines for the diagnosis and treatment of hepatocellur carcinoma (HCC) in adults. Gut 2003:52 (suppl 3): iii1-8.
26. Salem Riad. Journal of vascular and interventional radiology (JVIR) News Highlight. 16th February 2005.
27. Shiratori Y, Imazeki F, Moriyama M, Yano M, Arakawa Y, Yokosuka O, et al. Histologic improvement of fibrosis in patients with hepatitis C who have sustained response of interferon therapy. Ann Intern Med 2000;132:517-24.
28. Yoshida H, Shiratori Y, Moriyama M, Arakawa Y, Ide T, Sata M, Interferon reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. Ann Intern Med 1999; 131:174-81.
29. Yoshida H, Arakawa Y, Sata M, Nishiguchi S, Yano M, Fujiyama S, et al. Interferon therapy prolonged life expectancy among chronic hepatitis C patients. Gastroenterology 2002;123:483-91.
30. Shiratori Y, Shiina S, Teratini T, Imamura M, Obi S, Sato S, et al. Interferon therapy after tumor ablation improves prognosis in patients with hepatocellular carcinoma associated with hepatitis C virus. Ann Intern Med 2003; 138: 299-306.
31. Jolesz FA, Hynynen K. Magnetic resonance image-guided focused ultrasound surgery Cancer J 2002; 8:(suppl 1) S100-12.